Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: doxycycline + 0.26 + web  Related to the article below (Last Update: 8/4/2008)

Lannett Company Inc announces receipt of FDA approval for ...
Trading Markets (press release), CA -
Doxycycline Tablets are the generic equivalent of Adoxa, which is marketed by Par Pharmaceutical Inc. The combined sales of generic Doxycycline Tablets, ...LCI - OTC:CMTX
Lannett Company Receives FDA Approvals for Doxycycline Tablets, 75 ...
Business Wire (press release), CA - Aug 1, 2008
?The approvals of Doxycycline Tablets, 75 mg and 150 mg, round out our doxycycline portfolio, supplementing our 50 mg and 100 mg dosages,? said Arthur ...
Lannett says FDA OKs Doxycycline Tablets, 75 mg and 150 mg - quick ... RTT News
KV Set to Dispose of Previously Written Off Guaifenesin Inventory MarketWatch
Federal Agents Seize More Than $24 Million In Unapproved New Drugs Medical News Today (press release)
In-PharmaTechnologist.com - SunHerald.com
all 25 news articles »  KV.A - LCI - AMS:WKL
Pathogens & People: Lyme disease: The good, the bad and the silly
Annapolis Capital, MD - Aug 3, 2008
Instead of swallowing antibiotics such as doxycycline or amoxicillin for two to four weeks, a single injection of slow-release doxycycline hyclate should ...
FDA Safety Changes: Serevent Diskus, Letairis, Antibiotics
Medscape (subscription) - Jul 16, 2008
Cefotaxime is a third-generation cephalosporin antibiotic with a broad spectrum of activity against gram-positive and gram-negative bacteria, doxycycline is ...
Residents cautioned about tick-spread diseases
Pacific Daily News, GU - Jul 24, 2008
"When diagnosed early, almost all tick diseases are easily treated with Doxycycline," he said. "It's one of the least expensive antibiotics that exists. ...
Have We Finally Found an Effective Defense Against Lyme Disease?
Discover Magazine, NY - Jul 9, 2008
Now a new, long-acting preparation of the antibiotic doxycycline may help prevent Lyme and another tickborne infection. Researchers at New York Medical ...

PhysOrg.com
Once common on skin, anthrax is deadly in lungs
The Associated Press - Aug 1, 2008
The usual treatment is a common antibiotic, such as penicillin, doxycycline or Cipro. These medicines are extremely effective. Left untreated, perhaps 5 ...
Inhaled Form of Anthrax More Deadly Than Skin Infection RedOrbit
all 121 news articles »
Army scientist, investigated in anthrax attacks, killed himself as ...
Fort Worth Star Telegram, TX - Aug 1, 2008
The usual treatment is a common antibiotic, such as penicillin, doxycycline or Cipro. These medicines are extremely effective. ? AP.
Lyme disease spikes
Lancaster Newspapers, PA - Aug 2, 2008
Sisbarro said she prescribes a three-week dosage of the antibiotic doxycycline, a common treatment for the infection. "Anybody with any kind of rash" or ...
Anthrax attacks changed mail handling
Abilene Reporter-News, TX - Aug 1, 2008
The usual treatment is a common antibiotic, such as penicillin, doxycycline or Cipro. These medicines are extremely effective. Left untreated, perhaps 5 ...
Source: Google News

… the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline -
BO Kim, Y Liu, Y Ruan, ZC Xu, L Schantz, JJ He - American Journal of Pathology, 2003 - ASIP
... In the present study we modified the doxycycline (Dox)-regulated ... AIDS Compendium
on Line": http://hiv-web.lanl.gov ... the wild-type mice gained 4.51 ? 0.26 g (n ...

Respiratory disorders (acute) -
A Table - clinicalevidence.bmj.com
... 7, 0.9 v 0.9, WMD +0.03, 95% CI -0.20 to +0.26. ... Williamson 1984 [1], Doxycycline
(7 days), 74 adults (21?65 ... Web publication date: 01 Mar 2007 (based on July 2006 ...
-

Reversible blockade of experience-dependent plasticity by calcineurin in mouse visual cortex -
Y Yang, QS Fischer, Y Zhang, K Baumg?rtel, IM … - Nature Neuroscience, 2005 - nature.com
... text access provided to Googlebot Access by Web Services. ... be rescued later in life,
we started doxycycline treatment at ... 0.28 0.03 compared to WOD = 0.26 (in ref ...

[PDF] V. USAGE OF ANTIMICROBIAL AGENTS -
AUIN ANIMALS - CONTRIBUTORS AND PARTICIPANTS - nevrologi.no
... leaflets can be downloaded from this web page. ... 0.001 0.001 0.001 0.001 0.001 J01A
A02 Doxycycline 2.34 2.20 ... A04 Lymecycline 0.09 0.09 0.14 0.19 0.26 0.30 0.34 ...

Effect of Antibiotics on the Oropharyngeal Flora in Patients With Acne -
RM Levy, EY Huang, D Roling, JJ Leyden, DJ … - Archives of Dermatology, 2003 - Am Med Assoc
... your Web browser does not support basic Web standards ... 4/20; PRR, 0.69; 95% CI,
0.26-1.8; P ... antibiotic (tetracycline, minocycline, or doxycycline) compared with ...

Contributions of low molecule number and chromosomal positioning to stochastic gene expression -
A Becskei, BB Kaufmann, A van Oudenaarden - Nat Genet, 2005 - nature.com
... access provided to: Googlebot Access by: Web Services. ... and uncorrelated noises were
0.26 0.03 and ... YFP fluorescence, normalized by doxycycline concentration as ...

LYME DISEASE
SANN CALL - Clinical Primer of Rheumatology, 2003 - books.google.com
... 0.24 OM 23.06 55.06 0.16 0.00 1.12 0.38 0.10 4.45 1.84 0.26 1.10 9.57 ... about Lyme
disease from the Centers for Disease Control and Prevention's Web Site (www. ...
-

Bacterial Prophylaxis vs. Nonprophylaxis Policy in Patients (pts) with Hematopoietic Stem Cell …
HC MALTEZOU, DA KAFETIZIS, KV ROLSTON - Abstr Intersci Conf Antimicrob Agents Chemother Intersci …, 1999 - gateway.nlm.nih.gov
... vancomycin (62 pts), vancomycin/norfloxacin (56), penicillin/norfloxacin (8),
doxycycline/norfloxacin (2 ... 28%) pts of group A and 26 (44%) of group B (p=0.26). ...
-

Costs and health consequences of chlamydia management strategies among pregnant women in sub-Saharan … -
M Romoren, F Hussein, TW Steen, M Velauthapillai, … - British Medical Journal, 2007 - sti.bmj.com
... 15, w1?w4 For the w- references, please see the additional web reference list. ... 0.158
0.09 to 0.26 A ... Male compliant to doxycycline and drug effectiveness ...

Induction of Inflammatory Cytokines by a Keratin Mutation and their Repression by a Small Molecule … -
H Lu, J Chen, L Planko, P Zigrino, L Klein-Hitpass … - Journal of Investigative Dermatology, 2007 - nature.com
... text access provided to Googlebot Access by Web Services. ... of physiological
concentrations of doxycycline prolonged the ... with K5 -/- skin (Figure 2b, P=0.26). ...

Source: Google Scholar
 
 

Doxycycline slows progression of knee osteoarthritis

 
 
A study showed effectiveness of Doxycycline in slowing disease progression in patients with osteoarthritis.

Doxycycline, a tetracycline antibiotic, has been successfully used to treat a wide-range of bacterial infections.
In addition to its effects as an antibiotic, Doxycycline has other actions as a drug and, in laboratory studies with animals and with human tissue, can inhibit the degradation of cartilage in a way that could be useful for the treatment of osteoarthritis ( OA ).

Osteoarthritis is a common form of arthritis associated with pain and disability related to the breakdown of cartilage, the tissue in the joint that absorbs shock and promotes smooth movement .

On base of preclinical evidence, a team of rheumatologists affiliated with six clinical research centers across the United States conducted the first long-term clinical trial to determine the benefits of Doxycycline in the treatment of osteoarthritis, particularly, osteoarthritis of the knee.

The study suggests that Doxycycline may slow the progression of joint damage and point to the need for further research into the drug's effect on the signs and symptoms of this disease.

For the trial, the team recruited 431 overweight women between the ages of 45 and 64 with moderately advanced osteoarthritis in one knee.

The subjects were randomly assigned to receive either 100 milligrams of Doxycycline or a placebo twice a day for 30 months.

At baseline, the 2 treatment groups were roughly equal with respect to all demographic variables, body mass index, and types of drugs taken for pain, as well as for the x-ray severity of osteoarthritis in the affected knee and the level of knee pain and functional impairment.

Osteoarthritis progression was assessed by measuring joint space narrowing in the medial tibiofemoral compartment through X-rays obtained at baseline, 16 months and 30 months. Severity of joint pain was assessed every 6 months after a washout period of all nonsteroidal anti-inflammatory drugs ( NSAIDs ) and analgesics.

71 percent of the subjects completed the treatment protocol.
Radiographs were obtained from 85 percent of all subjects at 30 months.
After 16 months of treatment, the mean loss of joint space width in the diseased knee in the Doxycycline group was 40 percent less than in the placebo group.
After 30 months, it was 33 percent less.
Despite significantly slowing disease progression, Doxycycline did not reduce the severity of joint pain.
However, mean pain scores at baseline were low in both treatment groups, leaving only limited opportunity to demonstrate improvement in joint pain.
On the other hand, the drug significantly reduced the frequency with which subjects reported increases in knee pain 20 percent or greater than the level of pain they had at their previous semi-annual visit.

Doxycycline seemed to have no effect on joint space narrowing or pain in the relatively disease-free knee.
In both knees in both treatment groups, the rate of joint space narrowing was more than twice as rapid in subjects who reported frequent increases in pain than in those with a stable pain score.

"Joint pain may serve as an indicator of synovitis that leads to cartilage destruction," observes the study's leading author, Kenneth D. Brandt.

Throughout the trial, fewer than 5 percent of all subjects reported side effects.
In general, Doxycycline seemed to be well tolerated.
Subjects in the active treatment group experienced the unexpected side benefits of fewer urinary tract and upper respiratory tract infections than their placebo counterparts.

In this study, Doxcycyline showed benefits in slowing the rate of joint space narrowing in knees with established osteoarthritis.
Whether this drug has any value in the early treatment and symptomatic management of osteoarthritis, however, will require further investigation.

Source: Arthritis & Rheumatism, 2005
 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News9A ;

 

ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page